Clinical trial

Validation of 3-[11C]-OHB

NCT05232812

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2022-06-01

PhaseNA

Study timeline

Study start (actual)2022-06-01Date precision: day

Registry last updated2023-03-31

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diabetes Mellitus, Type 2verified · MONDO: type 2 diabetes mellitus

Heart Failureverified · MONDO: heart failure

Healthyunresolved

Interventions

3-[11C]-OHBRADIATION

Sponsors & collaborators

University of Aarhuslead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05232812 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.